These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24919583)

  • 1. Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: a nationwide cohort study.
    Huang YW; Yang SS; Fu SC; Wang TC; Hsu CK; Chen DS; Hu JT; Kao JH
    Hepatology; 2014 Sep; 60(3):807-14. PubMed ID: 24919583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study.
    Huang YW; Wang TC; Lin SC; Chang HY; Chen DS; Hu JT; Yang SS; Kao JH
    Clin Infect Dis; 2013 Dec; 57(12):1695-702. PubMed ID: 24051864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study.
    Huang YW; Wang TC; Yang SS; Lin SY; Fu SC; Hu JT; Liu CJ; Kao JH; Chen DS
    Aliment Pharmacol Ther; 2015 Oct; 42(7):902-11. PubMed ID: 26211742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study.
    Huang YW; Lee CL; Yang SS; Fu SC; Chen YY; Wang TC; Hu JT; Chen DS
    Am J Gastroenterol; 2016 Jul; 111(7):976-85. PubMed ID: 27166128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: a nationwide cohort study.
    Fu SC; Huang YW; Wang TC; Hu JT; Chen DS; Yang SS
    Aliment Pharmacol Ther; 2015 Jun; 41(11):1200-9. PubMed ID: 25846548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes Mellitus is Associated With Higher Risk of Developing Decompensated Cirrhosis in Chronic Hepatitis C Patients.
    Saeed MJ; Olsen MA; Powderly WG; Presti RM
    J Clin Gastroenterol; 2017 Jan; 51(1):70-76. PubMed ID: 27306942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients.
    Yen YH; Kuo FY; Kee KM; Chang KC; Tsai MC; Hu TH; Lu SN; Wang JH; Hung CH; Chen CH
    Dig Liver Dis; 2019 Jan; 51(1):142-148. PubMed ID: 30076015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C.
    Elkrief L; Chouinard P; Bendersky N; Hajage D; Larroque B; Babany G; Kutala B; Francoz C; Boyer N; Moreau R; Durand F; Marcellin P; Rautou PE; Valla D
    Hepatology; 2014 Sep; 60(3):823-31. PubMed ID: 24841704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of liver cirrhosis in patients with tuberculosis: a nationwide cohort study.
    Peng YC; Lin CL; Hsu WY; Chang CS; Yeh HZ; Kao CH
    Eur J Clin Invest; 2015 Jul; 45(7):663-9. PubMed ID: 25903030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriatic patients with chronic viral hepatitis do not have an increased risk of liver cirrhosis despite long-term methotrexate use: Real-world data from a nationwide cohort study in Taiwan.
    Tang KT; Chen YM; Chang SN; Lin CH; Chen DY
    J Am Acad Dermatol; 2018 Oct; 79(4):652-658. PubMed ID: 29753054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
    N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between steatosis and diabetes with hepatocellular carcinoma in non-genotype 3 chronic hepatitis C patients.
    Yen YH; Lin MT; Kuo FY; Chang KC; Tsai MC; Tseng PL; Wu CK; Lin JT; Hu TH; Lu SN; Wang JH; Hung CH; Chen CH
    Liver Int; 2018 Jun; 38(6):1064-1073. PubMed ID: 29164767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES.
    Li DK; Yan P; Abou-Samra AB; Chung RT; Butt AA
    Aliment Pharmacol Ther; 2018 Jan; 47(2):246-258. PubMed ID: 29105111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and outcomes of hepatitis C infection in elderly US Veterans.
    El-Serag HB; Kramer J; Duan Z; Kanwal F
    J Viral Hepat; 2016 Sep; 23(9):687-96. PubMed ID: 27040447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unit.
    Álvaro-Meca A; Jiménez-Sousa MA; Boyer A; Medrano J; Reulen H; Kneib T; Resino S
    BMC Infect Dis; 2016 Mar; 16():122. PubMed ID: 26979964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.
    Liu TL; Trogdon J; Weinberger M; Fried B; Barritt AS
    Dig Dis Sci; 2016 Nov; 61(11):3335-3345. PubMed ID: 27480088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response.
    Le AK; Zhao C; Hoang JK; Tran SA; Chang CY; Jin M; Nguyen NH; Yasukawa LA; Zhang JQ; Weber SC; Garcia G; Nguyen MH
    Aliment Pharmacol Ther; 2017 Sep; 46(6):605-616. PubMed ID: 28766727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
    Merchante N; Rivero-Juárez A; Téllez F; Merino D; José Ríos-Villegas M; Márquez-Solero M; Omar M; Macías J; Camacho A; Pérez-Pérez M; Gómez-Mateos J; Rivero A; Antonio Pineda J;
    Hepatology; 2012 Jul; 56(1):228-38. PubMed ID: 22278746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
    Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
    Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.
    Pineda JA; Aguilar-Guisado M; Rivero A; Girón-González JA; Ruiz-Morales J; Merino D; Ríos-Villegas MJ; Macías J; López-Cortés LF; Camacho A; Merchante N; Del Valle J;
    Clin Infect Dis; 2009 Oct; 49(8):1274-82. PubMed ID: 19772387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.